MIM
NKTR icon

MTM Investment Management’s Nektar Therapeutics NKTR Stock Holding History

MTM Investment Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.61K Hold
66
– – ﹤0.01% 596
2026
Q1 		$4.75K Hold
66
– – ﹤0.01% 592
2025
Q4 		$2.79K Hold
66
– – ﹤0.01% 618
2025
Q3 		$3.75K Buy
+66
New +$2.19K ﹤0.01% 620

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MTM Investment Management's NKTR Position: Q2 2026 in Review

MTM Investment Management held its Nektar Therapeutics (NKTR) position steady in Q2 2026 at 66 shares worth $4.61K. The position accounts for ﹤0.01% of the portfolio, ranked #596.

MTM Investment Management first reported a position in NKTR in Q3 2025 and has held it in 4 quarters since. The position peaked at $4.75K in Q1 2026. 240 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.

  • MTM Investment Management held 66 shares of Nektar Therapeutics worth $4.61K as of Q2 2026.
  • MTM Investment Management left its Nektar Therapeutics share count unchanged in Q2 2026.
  • Nektar Therapeutics made up ﹤0.01% of MTM Investment Management's portfolio in Q2 2026, its #596 holding.
  • MTM Investment Management first reported a position in Nektar Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • MTM Investment Management's Nektar Therapeutics position peaked at $4.75K in Q1 2026.
  • 240 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.

Based on MTM Investment Management's 13F filing for Q2 2026, filed 3 Aug 2026.